T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Graphic Packaging
GPK
$3.38B
| $16.2M | ﹤0.01% |
618,537
-690,604
| -53% | -$19.1M |
|
|
BCYC
1002
Bicycle Therapeutics
BCYC
$273M
| $16.2M | ﹤0.01% |
798,501
+396,855
| +99% | +$8.97M |
|
|
IPG
1003
DELISTED
Interpublic Group of Companies
IPG
| $16.1M | ﹤0.01% |
555,117
+12,887
| +2% | +$397K |
|
1004
CarMax
KMX
$8.5B
| $16.1M | ﹤0.01% |
219,293
+1,646
| +0.8% | +$119K |
|
1005
Atour Lifestyle Holdings
ATAT
$4.65B
| $16M | ﹤0.01% |
871,959
-11,962
| -1% | -$216K |
|
1006
Red Rock Resorts
RRR
$3.76B
| $16M | ﹤0.01% |
291,105
-87,088
| -23% | -$4.73M |
|
1007
Ollie's Bargain Outlet
OLLI
$4.62B
| $16M | ﹤0.01% |
162,687
+13,654
| +9% | +$1.09M |
|
1008
Summit Therapeutics
SMMT
$10.6B
| $15.9M | ﹤0.01% |
2,042,100
+2,008,955
| +6,061% | +$10.9M |
|
1009
Eastman Chemical
EMN
$8.47B
| $15.9M | ﹤0.01% |
162,443
+2,969
| +2% | +$295K |
|
1010
Albemarle
ALB
$16.1B
| $15.8M | ﹤0.01% |
165,449
+3,063
| +2% | +$364K |
|
1011
Cadre Holdings
CDRE
$1.46B
| $15.8M | ﹤0.01% |
469,434
+8,934
| +2% | +$294K |
|
1012
LKQ Corp
LKQ
$6.43B
| $15.8M | ﹤0.01% |
378,798
+9,272
| +3% | +$415K |
|
1013
Crown Holdings
CCK
$12.9B
| $15.6M | ﹤0.01% |
209,794
+10,810
| +5% | +$872K |
|
1014
Viking Holdings
VIK
$43.7B
| $15.5M | ﹤0.01% |
+457,985
| New | +$13.8M |
|
1015
BHP
BHP
$220B
| $15.5M | ﹤0.01% |
272,085
-143,224
| -34% | -$8.32M |
|
1016
Visteon
VC
$2.89B
| $15.5M | ﹤0.01% |
145,240
-38,846
| -21% | -$4.29M |
|
|
AUTL
1017
Autolus Therapeutics
AUTL
$572M
| $15.4M | ﹤0.01% |
4,414,087
-1,074,899
| -20% | -$4.64M |
|
1018
Qorvo
QRVO
$8.66B
| $15.3M | ﹤0.01% |
131,930
+1,001
| +0.8% | +$107K |
|
1019
Moog Inc Class A
MOG.A
$14B
| $15.3M | ﹤0.01% |
91,266
-6,951
| -7% | -$1.14M |
|
1020
APA Corp
APA
$14.2B
| $15.2M | ﹤0.01% |
514,932
-17,739
| -3% | -$549K |
|
1021
Magnolia Oil & Gas
MGY
$6.22B
| $15.2M | ﹤0.01% |
598,168
+3,995
| +0.7% | +$102K |
|
1022
KBR
KBR
$4.84B
| $15.1M | ﹤0.01% |
235,392
+291
| +0.1% | +$18.8K |
|
|
SKX
1023
DELISTED
Skechers
SKX
| $15.1M | ﹤0.01% |
218,084
-16,474
| -7% | -$1.09M |
|
1024
Acadia Pharmaceuticals
ACAD
$4.87B
| $15M | ﹤0.01% |
920,086
-3,079,464
| -77% | -$49.7M |
|
1025
UiPath
PATH
$8.3B
| $14.8M | ﹤0.01% |
1,168,278
-1,194,247
| -51% | -$20.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.